Research Grants 5 show all


$293.8K
2008

$311.3K
2010

$288.5K
2011

$277.8K
2012

Patents 132show all

  • 56
    A61K - Preparations for medical, dental, or toilet purposes
  • 40
    C12N - Microorganisms or enzymes
  • 39
    C08F - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
  • 11
    Y02A - Technologies for adaptation to climate change
  • 10
    B01D - Separation
  • 10
    B04B - Centrifuges
  • 6
    C07K - Peptides
  • 3
    C08L - Compositions of macromolecular compounds
  • 3
    F23G - Cremation furnaces
  • 2
    C02F - Treatment of water, waste water, sewage, or sludge

SEC Filings show all


30
8-K

10
D

5
10-Q

1
10-K

1
S-1

Contact Information

Seattle, WA
United States

SEC Form D Funding Events

DateOfferedSoldType
2013-12-17$1,540,015$0Debt, Option to Acquire, Security to be Acquired
2013-10-02$1,400,014$1,400,014Debt, Option to Acquire, Security to be Acquired
2013-07-11$1,400,014$500,005Debt, Option to Acquire, Security to be Acquired
2012-12-21$3,000,031$1,500,016Debt, Option to Acquire, Security to be Acquired
2012-07-06$1,600,016$1,600,016Debt, Option to Acquire, Security to be Acquired
2012-02-14$4,650,037$3,600,037Debt, Option to Acquire, Security to be Acquired
2010-02-22$1,216,583$1,216,583Equity
2008-03-06Unknown Unknown Other (Paper Filing)

Key Executives

  • Robert W. Overell
    Executive Officer, Director, Promoter
  • Steven Gillis
    Director
  • Brian G. Atwood
    Director
  • John D. Diekman
    Director
  • Paul H. Johnson
    Executive Officer, Director
  • Raymond Calvert
    Executive Officer
  • Andrew Leon
    Executive Officer
  • John A. Schmidt
    Director
  • Brian Atwood
    Director
  • John Diekman
    Director
  • Paul Johnson
    Executive Officer, Director
  • John Schmidt
    Director